Search for: "United States v. Burden" Results 9021 - 9040 of 9,844
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Nov 2008, 9:54 pm
Solicitor General, will argue for the United States as amicus. [read post]
8 Nov 2008, 1:48 am
Sept. 30, 2008), the United States Court of Appeals for the Second Circuit held that the fraud-on-the-market doctrine established in Basic Inc. v. [read post]
8 Nov 2008, 1:48 am
Sept. 30, 2008), the United States Court of Appeals for the Second Circuit held that the fraud-on-the-market doctrine established in Basic Inc. v. [read post]
4 Nov 2008, 10:07 am
The Court concludes therefore that there is insufficient evidence to show general causation.Federal and State Courts have consistently determined that the cause or causes of MCS (IEI) cannot be reliably established by scientific proof (see, e.g., Oppenheimer v United Charities of NY, 266 AD2d 116, 698 NYS2d 144 [1st Dept 1999]; Frank v State of New York, 972 F Supp 130 [ND NY 1997]). [read post]
2 Nov 2008, 1:58 pm
That was for the specific reason that one of the important Indian cases on the point - State of UP v. [read post]
27 Oct 2008, 6:13 pm
  However, the judge’s version omitted the broader language that opened the government’s proposal: “An enemy combatant is an individual who was part of or supporting forces engaged in hostilities against the United States or its coalition partners. [read post]
27 Oct 2008, 3:49 pm
Pruitt, No. 06-6002 Given the particular characteristics of North Carolina sentencing law, in light of recent United States Supreme Court precedent, in determining whether to apply the career offender provision of the United States Sentencing Guidelines, a federal court must take into account the defendant's state criminal history (or lack thereof) at the time of his predicate North Carolina convictions. [read post]
27 Oct 2008, 10:27 am
Oct. 15, 2008), a unanimous panel of the United States Court of Appeals for the Federal Circuit affirmed the summary judgment granted to Bayer by the United States District Court for the Eastern District of New York, holding that Bayer’s settlement of patent litigation with a generic pharmaceutical manufacturer did not violate the antitrust laws. [read post]